Guild Investment Management, Inc. Biomarin Pharmaceutical Inc Transaction History

Guild Investment Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$71.48 - $86.85 $45,032 - $54,715	-630 Reduced 5.01%	11,940 $1.02 Million
Q1 2022 May 10, 2022	SELL	$74.28 - $92.69 $1,411 - $1,761	-19 Reduced 0.15%	12,570 $969,000
Q4 2021 Jan 18, 2022	BUY	$71.72 - $91.47 $645 - $823	9 Added 0.07%	12,589 $1.11 Million
Q3 2021 Oct 26, 2021	SELL	$74.77 - $85.47 $8,673 - $9,914	-116 Reduced 0.91%	12,580 $972,000
Q2 2021 Jul 28, 2021	BUY	$75.51 - $84.79 $241,329 - $270,988	3,196 Added 33.64%	12,696 $1.06 Million
Q1 2021 Apr 19, 2021	BUY	$74.73 - $90.69 $44,090 - $53,507	590 Added 6.62%	9,500 $717,000
Q4 2020 Jan 14, 2021	BUY	$72.61 - $90.2 $434,933 - $540,298	5,990 Added 205.14%	8,910 $781,000
Q3 2020 Oct 13, 2020	SELL	$71.87 - $131.03 $718 - $1,310	-10 Reduced 0.34%	2,920 $222,000
Q2 2020 Aug 12, 2020	BUY	$79.55 - $124.22 $233,081 - $363,964	2,930 New	2,930 $361,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Guild Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Guild Investment Management, Inc. with notifications on news.